AzurRx BioPharma (AZRX) to Acquire Payment Rights to Lead Drug Candi...

12/12/18

AzurRx BioPharma (AZRX) to Acquire Payment Rights to Lead Drug Candidate MS1819-SD from Protea Biosciences Group  StreetInsider.com

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

[more]